Matthew Giegengack is an accomplished inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of ophthalmology, particularly in corneal transplant procedures. With a total of 2 patents, Giegengack's work focuses on enhancing the stability and effectiveness of corneal implants.

Latest Patents

Giegengack's latest patents revolve around systems and methods for corneal transplants. These procedures often involve suturing an implant of healthy corneal tissue to a recipient cornea. However, the sutures can lead to unwanted deformation of both the corneal implant and the recipient cornea. To address this issue, Giegengack has developed a supporting structure that can be embedded into the corneal implant. This innovation aims to enhance the stability of the corneal implant and reduce the likelihood of deformation during the suturing process. One embodiment of his corneal implant includes donor corneal tissue with an interior channel formed at a depth below the anterior surface, along with a supporting structure made from non-tissue material positioned within the channel.

Career Highlights

Giegengack has established himself as a key figure in the field of corneal transplants. His innovative approaches have the potential to improve patient outcomes and streamline surgical procedures. His work is recognized for its practical applications in enhancing the effectiveness of corneal implants.

Collaborations

Giegengack collaborates with notable professionals in his field, including Jerry W Barker and Douglas C Drabble. These partnerships contribute to the advancement of research and development in corneal transplant technologies.

Conclusion

Matthew Giegengack's contributions to corneal transplant procedures demonstrate his commitment to innovation in ophthalmology. His patents reflect a deep understanding of the challenges faced in this field and offer promising solutions for improved surgical outcomes.

Profile summary based on public USPTO records.